Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20192
20201
20211
20222
20232
20242
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Unknown status7
Completed2
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Essen Biotech3
Beijing Tiantan Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Bayer1
Beijing Biotech1
Beijing Neurosurgical Institute1
First Affiliated Hospital of Wenzhou Medical University1
Guangzhou Virotech Pharmaceutical Co., Ltd.1
Jecho Biopharmaceuticals Co., Ltd.1
Man Hu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma20
Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Glioma3
Neoplasm Metastasis3
Ovarian Neoplasms3
Prostatic Neoplasms3
Breast Neoplasms2
Carcinoma, Hepatocellular2
Colorectal Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.